Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: VTRS

Viatris Inc.

Healthcare | Drug Manufacturers - Specialty & Generic

Market prices for VTRS are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2025)$-3.00

Viatris Inc. (NASDAQ: VTRS) is a specialty and generic drug manufacturer. Figures from SEC EDGAR; updated 2026-10-19 20:44 UTC.

What Viatris Inc. does

Viatris is a global healthcare company that supplies medicines to approximately one billion patients annually across more than 165 countries and territories. The company operates a diverse portfolio consisting of generic drugs, established brand-name medicines, and innovative pharmaceutical products, supported by more than 1,400 approved molecules and 27 manufacturing and distribution sites worldwide.

Summarized from Viatris Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (FY2025)$-3.00
Debt/equity0.94

Revenue, margins & earnings

FY2021: net loss $1.27B on revenue $17.9B$17.9BFY2021FY2022 Revenue: $16.3B — margin split not shown (non-operating gains)$16.3BFY2022FY2023 Taxes & interest: $712MFY2023 Operating expenses: $5.67BFY2023 Cost of revenue: $8.99B$15.4BFY2023FY2024: net loss $634M on revenue $14.7B$14.7BFY2024FY2025: net loss $3.51B on revenue $14.3B$14.3BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-02
  • 2026-10-02DirectorDeferred Stock UnitsAward2,469$43.8K
  • 2026-10-02DirectorDeferred Stock UnitsAward2,117$37.5K
  • 2026-08-18See RemarksTax withholding-435$7.1K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Viatris Inc. do?

Viatris is a global healthcare company that supplies medicines to approximately one billion patients annually across more than 165 countries and territories.

When did VTRS last file with the SEC?

Viatris Inc.'s most recent SEC filing on record is a SCHEDULE 13G/A filed 2026-09-08. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-19 20:44 UTC. This page is also available as JSON at /api/data?ticker=VTRS and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for VTRS and 5,000+ tickers.

Create a free account — keep VTRS
For your agent
GET /api/data?ticker=VTRS

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt